| CAT No: | CL-TZP-02 |
| CAS No: | NA |
| Mol.F: | C19H10D4F2N6O |
| Mol.Wt.: | 384.4 |
| Chemical Name: | (8S,9R)-5-Fluoro-8-(4-fluorophenyl-2,3,5,6-d4)-9-(1-methyl-1H-1,2,4-triazol-5-yl)-2,7,8,9-tetrahydro-3H-pyrido[4,3,2-de]phthalazin-3-one |
| Inventory Status: | Custom synthesis |
This impurity is related to Talazoparib d4 is provided with comprehensive characterization data in accordance with regulatory guidelines. It is suitable for use in analytical method development, method validation (AMV), Quality Control (QC) applications for Abbreviated New Drug Applications (ANDA) and commercial production of Asenapine.
Talazoparib d4 is used as a reference standard in analytical research. It ensures consistency of formulations.
Chemical Name:(8S,9R)-5-Fluoro-8-(4-fluorophenyl-2,3,5,6-d4)-9-(1-methyl-1H-1,2,4-triazol-5-yl)-2,7,8,9-tetrahydro-3H-pyrido[4,3,2-de]phthalazin-3-oneCountry of Origin: India Product Category: Impurity Reference StandardAPI NAME: Talazoparib Molecular Formula: C19H10D4F2N6O
Molecular Weight: 384.4
Storage: Store in a cool, dry place.
| Product Name: | Talazoparib d4 |
| CAS No: | NA |
| Mol.F.: | C19H10D4F2N6O |
| Mol.Wt.: | 384.4 |
Cat. No: CL-TZP-01
CAS No: 1373431-65-2
Mol. F: C19H10D4F2N6O
Mol. Wt: 384.4
Inv. Status: Custom Synthesis
Cat. No: CL-TZP-NO-01
CAS No: NA
Mol. F: C19H13F2N7O2
Mol. Wt: 409.4
Inv. Status: Custom Synthesis
Cat. No: CL-TZP-NO-02
CAS No: NA
Mol. F: C19H12F2N8O3
Mol. Wt: 438.1
Inv. Status: Custom Synthesis
Cat. No: CL-TZP-NO-03
CAS No: NA
Mol. F: C19H13F2N7O2
Mol. Wt: 409.36
Inv. Status: Custom Synthesis
Cat. No: CL-TZP-NO-04
CAS No: NA
Mol. F: C18H11F2N7O2
Mol. Wt: 395.33
Inv. Status: Custom Synthesis
Cat. No: CL-TZP-NO-05
CAS No: NA
Mol. F: C18H9F2N9O4
Mol. Wt: 453.33
Inv. Status: Custom Synthesis
Catalog No:
CAS No:
Mol. Formula:
Mol. Weight:
Chemical Name
Inv Status: